Madison-based Mithridion seeks to capitalize on Alzheimer's breakthrough
Springing out of a promising research breakthrough on Alzheimer'?s disease, UW-Madison researcher Jeff Johnson has co-founded Mithridion Inc. in hopes of commercializing an Alzheimer'?s-inhibiting drug....